Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | ABBV | GILD |
|---|
| Close | 294.89 | 170.68 |
| Market Cap | $522B | $213B |
| 1M | +12.73% | +14.51% |
| P/E (TTM) | 81.4 | — |
| Forward P/E | 16.9 | 22.0 |
| P/E 5-Yr Percentile | 62 | — |
| P/S | 8.0 | 7.0 |
| P/B | — | 17.9 |
| Dividend Yield | 4.47% | 3.98% |
| Latest Quarter Revenue | $17.0B | $8.3B |
| Revenue YoY | +10.2% | +6.8% |
| Gross Margin | 74.7% | 81.1% |
| Latest Quarter EPS | 2.03 | 1.94 |
| Avg Post-Earnings Move | ±1.7% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 2.57% |
| 90-Day Net Insider Buying | −$8.2M | −$15.9M |
ABBV · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
